SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is seeing heightened volatility as markets digest TSMC's comments regarding the high cost of next-generation High-NA EUV machinery, leading some investors to debate the timeline for adoption versus the company's entrenched lithography monopoly. Despite the pullback, the community remains intensely focused on the stock's role as the indispensable bottleneck for AI infrastructure, with many traders framing the price dip as a long-term accumulation opportunity.

Based is a financial superapp built on Hyperliquid that lets users trade crypto, equities, and commodities from a single interface, fund accounts directly from bank accounts or credit cards, and spend balances at over 100 million merchants worldwide using a Visa Platinum card that converts at the point of sale with no separate off-ramp required. The platform operates across web, iOS, Android, and desktop with one account, and includes features like curated Launchpools for early project access and AI-native wallets for autonomous trading and risk monitoring.

Based Token

BASED is currently seeing heightened community activity and volatility as traders speculate on its potential within the broader Base chain ecosystem. The sentiment is polarized, with some investors betting on its utility-driven app model while others express caution regarding price swings and the speculative nature of the project.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending following the announcement of an upcoming FDA advisory committee meeting for Deramiocel and the release of positive five-year clinical data. The community is actively debating whether this committee serves as a pathway for broader regulatory approval or represents a source of renewed uncertainty regarding the path to commercialization.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is seeing heightened community discourse as investors balance optimism over its pivot toward AI-integrated network infrastructure with frustration regarding recent downward price volatility and institutional rotation. While the stock continues to attract interest based on its photonics moat and potential as a national security play in the 5G/6G space, traders are actively debating whether current support levels represent a strategic accumulation opportunity ahead of upcoming quarterly earnings or a deeper technical correction.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid intense community polarization over the company's financial disclosures and ongoing crypto-related controversies. Investors are actively debating the potential for future volatility as they weigh the impact of shifting political dynamics and market rumors against the stock's recent performance.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

Seagate Technology and the broader memory sector are trending as investors weigh the impact of potential production capacity constraints against sustained, AI-driven demand. Community discourse is heavily split between bulls focused on tight supply and favorable long-term fundamentals, and bears concerned that high-flying valuations reflect an overextended cycle prone to volatility.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as investors debate whether the recent double-digit decline represents a structural breakdown or a significant accumulation opportunity following a guidance adjustment and accelerated share repurchase program. While some market participants express frustration over persistent selling pressure, many community members are aggressively loading shares, viewing the current valuation as disconnected from long-term fundamentals and potential M&A catalysts.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus Energy is gaining traction as investors focus on its critical role in the U.S. nuclear fuel supply chain, particularly following its recent S&P SmallCap 600 inclusion and significant Department of Energy contract wins. The community remains highly focused on the company's unique position as a domestic supplier of HALEU and its long-term strategic importance in powering the next generation of small modular reactors.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

Immuneering Corp

Immuneering Corp (IMRX) is seeing significant investor attention following a positive clinical data update for atebimetinib in first-line metastatic pancreatic cancer, with community sentiment buoyed by the stock's favorable cash runway into 2029. The stock is currently trending as a high-asymmetry biotech play, with market participants actively discussing its potential for M&A, its role in the RAS-inhibitor landscape, and the significance of its upcoming oral presentation at the ASCO annual meeting.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea Ltd is seeing heightened market activity as traders debate whether the sharp post-earnings sell-off represents a structural collapse or a rare entry point for a high-growth asset. The community is actively parsing mixed earnings results against aggressive insider selling and regional macro pressures, with many focused on whether current support levels will hold or if the stock is headed for deeper accumulation zones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Research Reports for Applied Materials, Mastercard & AbbVie

Applied Materials is riding AI-driven chip demand, but can record margins, new products and China-related risks shape its next phase of growth?

J&J or AbbVie: Which Stock Deserves a Place in Your Portfolio Now?

JNJ and ABBV both offer solid long-term growth potential, but differences in diversification, pipeline strength and estimates may give one stock an edge.

Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today

AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 5.03% on an annualized basis producing an average annual return of 16.59%. Currently, AbbVie has a market capitalization of $442.79 billion.read more...

J&J's Innovative Medicine Business in Q2: Here's What to Watch

JNJ's Q2 Innovative Medicine results face scrutiny as Stelara biosimilar pressure offsets growth from key blockbusters and newer therapies ahead of earnings.

What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week?

ABBV surged nearly 11% in a week as acquisitions, new approvals and pipeline expansion strengthen confidence in its long-term growth strategy.

Genmab/AbbVie Lymphoma Trial Meets Main Goal, Analyst Eyes Bigger Market Opportunity

Genmab reports positive Phase 3 EPCORE DLBCL-4 results in relapsed lymphoma; analyst points to label expansion and future growth opportunities.read more...

Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report

US lawmakers probe Merck and AbbVie over national security and ethical risks tied to clinical trials conducted in China.read more...

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know  

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.

Nxera Receives $10 Mln Milestone Payment From AbbVie

(RTTNews) - Nxera Pharma Co., Ltd. (SOLTF) on Tuesday said it received a $10 million milestone payment from AbbVie (ABBV) after achieving a fourth R&D milestone under their multi-target drug discovery collaboration focused on neurological diseases...

AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma PR...

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

Why Did INTC, KEEL, APGE Stocks Hit 52-Week Highs Today?

Equity

Neutral Sentiment

Track ABBV stock price, charts, news and real-time market activity on Stocktwits. Join the ABBV message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around AbbVie Inc stock.

ABBV Stock Price Today - Abbvie Inc News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$3.76	--	--	N/A
Q1 '26	$2.59	$2.65	2.23%	BEAT
Q4 '25	$2.65	$2.71	2.15%	BEAT
Q3 '25	$1.77	$1.86	5.32%	BEAT
Q2 '25	$2.88	$2.97	3.12%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

ABBVAbbvie Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest ABBV News